Analystreport

Oncternal Therapeutics, Inc. (NASDAQ: ONCT) was upgraded by analysts at HC Wainwright from a "neutral" rating to a "buy" rating.

Oncternal Therapeutics, Inc.  (ONCT) 
Last oncternal therapeutics, inc. earnings: 8/8 04:01 pm Check Earnings Report